Aspirin/dabigatran-etexilate/rivaroxabanHeavy menstrual bleedings, upper gastrointestinal bleeding and lack of efficacy.: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1817卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82027-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：68 / 68

相关论文

共 50 条

[1] Aspirin/dabigatran-etexilate/meloxicam/rivaroxabanMajor bleedings: 13 case reports
Reactions Weekly, 2015, 1579 (1) : 61 - 61
[2] Aspirin/dabigatran-etexilate/warfarinLack of efficacy and gastrointestinal bleed: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 245 - 245
[3] Dabigatran-etexilate/warfarinHaematuria and gastrointestinal bleeding: 2 case reports
Reactions Weekly, 2021, 1863 (1) : 117 - 117
[4] Apixaban/dabigatran-etexilate/rivaroxabanBleeding and lack of efficacy: 3 case reports
Reactions Weekly, 2024, 2028 (1) : 69 - 69
[5] Aspirin/dabigatran-etexilate/rivaroxabanBleeding: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 75 - 75
[6] Dabigatran-etexilate/rivaroxabanMid-gastrointestinal bleeding.: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 194 - 194
[7] Dabigatran-etexilate/streptokinaseUpper gastrointestinal bleeding: case report
Reactions Weekly, 2020, 1808 (1) : 101 - 101
[8] Dabigatran-etexilate overdoseUpper gastrointestinal bleeding and haemorrhagic shock: 2 case reports
Reactions Weekly, 2018, 1730 (1) : 111 - 111
[9] Dabigatran-etexilate/rivaroxabanMinor hemorrhagic complication and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1974 (1) : 123 - 123
[10] Dabigatran-etexilate/idarucizumabBleeding and lack of efficacy : case report
Reactions Weekly, 2024, 2021 (1) : 166 - 166

← 1 2 3 4 5 →